Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Bone Growth Stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone growth stimulators market in China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bone growth stimulators market in China was Orthofix Holdings Inc followed by DJO Global, ZimVie and Bioventus.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Bone Growth Stimulators apply electrical or ultrasound waves to the site of the fracture/fusion. The usage of the stimulators for the following bones are tracked here: radius, ulna, tibia, fibula, clavicle, scapula, humerus and femur. Bone Growth Stimulators can be either External or Implantable Devices. External Bone Growth Stimulators are the stimulation devices which are worn outside the skin and do not require any surgical intervention. Implantable Bone Growth Stimulators are the stimulation devices which are implanted during surgery to stabilize the fracture.
The bone growth stimulators market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size bone growth stimulators in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
